Our data suggested that tRF-17-79MP9PP inhibits the THBS1-mediated TGF-β1/Smad3 pathway and the EMT related genes (MMP3, MMP-9 and N-cadherin) in breast cancer cells. This evidence concerns the gene MMP3 and breast carcinoma.